US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
BioNexus Gene Lab Corporation (BGLC)
BioNexus Gene Lab Corporation (BGLC) ニュース

BGLC

BioNexus Gene Lab (BGLC)

BioNexus Gene Lab Corporation

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:BGLC

1

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/01	04 : 47	Edgar (US Regulatory)	Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/06/01	04 : 46	Edgar (US Regulatory)	Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/06/01	04 : 46	Edgar (US Regulatory)	Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/06/01	04 : 45	Edgar (US Regulatory)	Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/06/01	04 : 45	Edgar (US Regulatory)	Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/05/10	01 : 37	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/04/19	03 : 52	GlobeNewswire Inc.	BioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in Healthcare	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/01/27	06 : 05	Edgar (US Regulatory)	Form PRE 14C - Other preliminary information statements	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/01/23	21 : 55	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2023/11/03	23 : 55	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2023/09/08	00 : 17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2023/07/25	06 : 28	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2023/07/25	00 : 30	GlobeNewswire Inc.	BioNexus Gene Lab Corp. Announces Closing of $5.75 Million Public Offering and Full Exercise of Over-Allotment Option and Uplisting to the Nasdaq Capital Market	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2023/07/21	02 : 29	GlobeNewswire Inc.	BioNexus Gene Lab Corp. Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital Market	NASDAQ:BGLC	BioNexus Gene Lab Corporation

Showing the most relevant articles for your search:NASDAQ:BGLC

1

Bank of America

Energy Select Sector SPDR

US Dollar vs Yen

Deutsche Telekom (QX)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約